BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17237905)

  • 21. Lynch syndrome screening in newly diagnosed colorectal cancer in general pathology practice: from the revised Bethesda guidelines to a universal approach.
    Morrison J; Bronner M; Leach BH; Downs-Kelly E; Goldblum JR; Liu X
    Scand J Gastroenterol; 2011 Nov; 46(11):1340-8. PubMed ID: 21879804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Family history of colorectal cancer in Iran.
    Mahdavinia M; Bishehsari F; Ansari R; Norouzbeigi N; Khaleghinejad A; Hormazdi M; Rakhshani N; Malekzadeh R
    BMC Cancer; 2005 Sep; 5():112. PubMed ID: 16143045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
    Carethers JM; Stoffel EM
    World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
    Umar A; Boland CR; Terdiman JP; Syngal S; de la Chapelle A; Rüschoff J; Fishel R; Lindor NM; Burgart LJ; Hamelin R; Hamilton SR; Hiatt RA; Jass J; Lindblom A; Lynch HT; Peltomaki P; Ramsey SD; Rodriguez-Bigas MA; Vasen HF; Hawk ET; Barrett JC; Freedman AN; Srivastava S
    J Natl Cancer Inst; 2004 Feb; 96(4):261-8. PubMed ID: 14970275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular testing for microsatellite instability and DNA mismatch repair defects in hereditary and sporadic colorectal cancers--ready for prime time?
    Søreide K
    Tumour Biol; 2007; 28(5):290-300. PubMed ID: 17962726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer.
    Ponz de Leon M; Benatti P; Di Gregorio C; Pedroni M; Losi L; Genuardi M; Viel A; Fornasarig M; Lucci-Cordisco E; Anti M; Ponti G; Borghi F; Lamberti I; Roncucci L
    Br J Cancer; 2004 Feb; 90(4):882-7. PubMed ID: 14970868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and molecular analysis of hereditary non-polyposis colorectal cancer in Chinese colorectal cancer patients.
    Wang J; Luo MH; Zhang ZX; Zhang PD; Jiang XL; Ma DW; Suo RZ; Zhao LZ; Qi QH
    World J Gastroenterol; 2007 Mar; 13(10):1612-7. PubMed ID: 17461458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)].
    Vasen HF
    Fam Cancer; 2005; 4(3):219-25. PubMed ID: 16136381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recommendations to improve identification of hereditary and familial colorectal cancer in Europe.
    Vasen HF; Möslein G; Alonso A; Aretz S; Bernstein I; Bertario L; Blanco I; Bulow S; Burn J; Capella G; Colas C; Engel C; Frayling I; Rahner N; Hes FJ; Hodgson S; Mecklin JP; Møller P; Myrhøj T; Nagengast FM; Parc Y; Ponz de Leon M; Renkonen-Sinisalo L; Sampson JR; Stormorken A; Tejpar S; Thomas HJ; Wijnen J; Lubinski J; Järvinen H; Claes E; Heinimann K; Karagiannis JA; Lindblom A; Dove-Edwin I; Müller H
    Fam Cancer; 2010 Jun; 9(2):109-15. PubMed ID: 19763885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing.
    Terdiman JP; Gum JR; Conrad PG; Miller GA; Weinberg V; Crawley SC; Levin TR; Reeves C; Schmitt A; Hepburn M; Sleisenger MH; Kim YS
    Gastroenterology; 2001 Jan; 120(1):21-30. PubMed ID: 11208710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].
    Schneider R; Schneider C; Büttner R; Reinacher-Schick A; Tannapfel A; Fürst A; Rüschoff J; Jakobeit C; Royer-Pokora B; Möslein G
    Zentralbl Chir; 2015 Dec; 140(6):591-9. PubMed ID: 25372301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microsatellite instability in colorectal-cancer patients with suspected genetic predisposition.
    Calistri D; Presciuttini S; Buonsanti G; Radice P; Gazzoli I; Pensotti V; Sala P; Eboli M; Andreola S; Russo A; Pierotti M; Bertario L; Ranzani GN
    Int J Cancer; 2000 Jan; 89(1):87-91. PubMed ID: 10719736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review article: Detection and management of hereditary non-polyposis colorectal cancer (Lynch syndrome).
    Ramsoekh D; Van Leerdam ME; Wagner A; Kuipers EJ
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():101-11. PubMed ID: 18081654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
    Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Nakagawa H; Sotamaa K; Prior TW; Westman J; Panescu J; Fix D; Lockman J; Comeras I; de la Chapelle A
    N Engl J Med; 2005 May; 352(18):1851-60. PubMed ID: 15872200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing.
    Zhang L
    J Mol Diagn; 2008 Jul; 10(4):301-7. PubMed ID: 18556776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer.
    Cross DS; Rahm AK; Kauffman TL; Webster J; Le AQ; Spencer Feigelson H; Alexander G; Meier P; Onitilo AA; Pawloski PA; Williams AE; Honda S; Daida Y; McCarty CA; Goddard KA;
    Genet Med; 2013 Dec; 15(12):933-40. PubMed ID: 23639899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis.
    de Leon MP; Pedroni M; Benatti P; Percesepe A; Di Gregorio C; Foroni M; Rossi G; Genuardi M; Neri G; Leonardi F; Viel A; Capozzi E; Boiocchi M; Roncucci L
    Gut; 1999 Jul; 45(1):32-8. PubMed ID: 10369701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting.
    Ramsoekh D; Wagner A; van Leerdam ME; Dinjens WN; Steyerberg EW; Halley DJ; Kuipers EJ; Dooijes D
    Gut; 2008 Nov; 57(11):1539-44. PubMed ID: 18625694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC-like families: Problems in diagnosis, surveillance, and management.
    Lynch HT; Riley BD; Weissman SM; Coronel SM; Kinarsky Y; Lynch JF; Shaw TG; Rubinstein WS
    Cancer; 2004 Jan; 100(1):53-64. PubMed ID: 14692024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The novel germline mutation of the hMLH1 gene in a case of suspected hereditary non-polyposis colorectal cancer (HNPCC) in a patient with no family history of cancer.
    Tomita N; Fukunaga M; Okamura S; Nakata K; Ohzato H; Tamura S; Sugimoto K; Aihara T; Miki H; Takatsuka Y; Matsuura N; Ishikawa H; Iwanaga T; Fukayama N; Sugano K
    Jpn J Clin Oncol; 2004 Sep; 34(9):556-60. PubMed ID: 15466831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.